Introduction
Pateamine A (pateamine; Fig. 1 ) is a novel thiazole-containing natural product, fi rst isolated in the early 1990's from samples of the marine sponge Mycale hentscheli collected off the southwest coast of the South Island of New Zealand (Northcote et al., 1991) . The biological activity of pateamine has been well characterized; it is highly toxic to a wide array of mammalian cell lines and has antifungal activity, but is essentially inactive against prokaryotes (Northcote et al., 1991) . A number of detailed studies have been undertaken with pateamine itself or with desmethyl des-amino pateamine A (DMDA-PatA), a simplifi ed analogue that retains activity comparable to the natural product (Romo et al., 2004) . Like pateamine, DMDA-PatA shows a surprising lack of variability in activity towards a range of cell lines under normal growth conditions, with IC 50 values typically within the 0.2 -10 nM range for non-quiescent cells (Kuznetsov et al., 2009 ). There is a signifi cant difference in this activity between dividing and quiescent cells with quiescent cells being characterized as approximately 1000- (Kuznetsov et al., 2009 ) to 2000-fold (Northcote et al., 1991) less sensitive.
This wide-spectrum activity and specifi city for dividing cells suggest that pateamine interacts with one or more targets that are fundamental to eukaryotic cell survival and proliferation. Studies designed to determine the target of pateamine identifi ed that it inhibits protein synthesis through inhibition of cap-dependent translation, and have revealed that members of the eukaryotic initiation factor 4A (eIF4A) family are mediators of this activity (Bordeleau et al., 2005; Dang et al., 2009) . Members of the eIF4A family are ATP-dependant RNA helicases (Grifo et al., 1983) and are the archetypal DEAD box helicases. There are three members of the eIF4A family in humans: eIF4AI and eIF4AII form a key component of the eIF4F complex that recruits the ribosome to a newly exported mRNA transcript (Conroy et al., 1990; Grifo et al., 1983; Yoderhill et al., 1993) and melts secondary structure in the mRNA 5`-UTR immediately proximal to the cap allowing the ribosome to access the start codon (Pause et al., 1994; Ray et al., 1985; Svitkin et al., 2001) . The third member of the eIF4A family in humans, eIF4AIII, is required for non-sense-mediated mRNA decay (NMD) as
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Although the eIF4A proteins are well-established as the most likely mediators of the activity of pateamine and its close analogues, there are indications that additional targets may contribute to this activity (Bordeleau et al., 2005) and potentially explain the complex structure-activity relationships exhibited by pateamine analogues (Romo et al., 2004) . Recently Kuznetsov and coworkers (2009) have shown that DMDA-PatA causes some cell lines to arrest in the S-phase and have demonstrated direct inhibition of DNA polymerases α and γ, but at concentrations above those reported for in vitro or cellular activity against eIF4A.
As part of our study into its activity we generated a pateamine affi nity resin to isolate cytosolic binding targets in an impartial fashion. In addition to the eIF4A family we identifi ed cytokeratin and tubulin as proteins selectively isolated from HL-60 cells (Bordeleau et al., 2005) . Whilst the interaction between pateamine and eIF4A was demonstrated to be functional and to occur at concentrations relevant to pateamine's cytotoxicity, the evaluation of the interaction with cytoskeletal elements remained unresolved. Herein we report the extension of the affi nity chromatography study to include HeLa and SH-SY5Y cells, the consistent isolation of tubulin and actin but not cytokeratin as binding partners in addition to eIF4A, and the in vitro assessment of the impact of pateamine on the assembly of actin fi laments and microtubules. We show that pateamine has the capacity to disrupt the cytoskeleton, but only at concentrations above those required for protein synthesis inhibition.
Results

Pateamine is cytotoxic to cultured cells
To ensure that the batches of pateamine supplied for this study were of comparable biological activity to samples tested in previous studies and to account for batch-to-batch variations in purity a standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Mosmann, 1983 ) was performed after 24 h exposure to pateamine with the three cell lines used for subsequent binding protein studies: leukemic HL-60 cells (Gallagher et al., 1979) , cervical epithelial HeLa cells (Scherer and Hoogasian, 1954) , and the neuroblastoma cell line SH-SY5Y (Biedler et al., 1978) . Pateamine displayed similar cytotoxicity in the three cell lines with IC 50 values of (1.43  0.06) nM, (1.5  0.04) nM, and (1.98  0.08) nM for HL-60, HeLa, and SH-SY5Y cells, respectively. These values are comparable to those previously published (Hood et al., 2001) .
Identifi cation of putative pateamine-binding proteins
Across each of the HL-60, HeLa, and SH-SY5Y cell lysates tested, only three proteins, 1 -3, were consistently eluted from the pateamine resin that did not appear in the control resin (Fig. 2, lanes B, D, and F). The three putative pateamine-binding proteins were identifi ed by peptide mass fi ngerprinting after trypsin digestion. In all cell lines except SH-SY5Y, binding protein 1 was identifi ed as being a member of the β-tubulin family, however, the specifi c isotype(s) could not be determined due to a lack of discriminating peptides in the mass spectra. Whilst the band 1 from SH-SY5Y cells was of the same apparent molecular weight as that from the other cell lines, no signifi cant hits were obtained from the mass fi ngerprinting. Binding protein 2 was identifi ed as eukaryotic initiation factor 4A (eIF4A) as pre viously reported (Bordeleau et al., 2005) . Analysis of the mass spectral information confi rmed the presence of all three isoforms for each cell line tested consistent with our earlier identifi cation of eIF4AI, -II, and -III from the HL-60 cell line (Bordeleau et al., 2005) . Gel band 3 was identifi ed as β/γ-actin from each of the three cell lines; no discriminating peptides were found to allow us to identify whether one or both isoforms were present. Lowabundance proteins and those not evident in all cell lines were not investigated. Two commonly seen higher-molecular weight bands at approximately 60 and 55 kDa were identifi ed as originating from cytokeratin which was also identifi ed in the control resin.
Pre-incubation of the HL-60 cell lysate with pateamine prevented the binding of any of the three previously recovered proteins to the pateamine resin and consequently there were no signifi cant differences between the pateamine and control resins (Fig. 2 , lane H). Washing the affi nity resin with 1 M sodium chloride signifi cantly decreased the amount of bands 1 and 3, but not of band 2 (Fig. 2 , lane I), as confi rmed by mass spectrometry highlighting a difference in the nature of the interaction of pateamine with actin and tubulin as compared to eIF4A.
Pateamine displays dual effects on in vitro microtubule polymerization
We used a turbidity assay to measure the effect of pateamine on microtubule polymerization which has been shown to be particularly valid for systems with low rates of nucleation (Hall and Minton, 2005) . The effect of pateamine on the polymerization of bovine brain tubulin was compared to those of paclitaxel and colchicine which are known to enhance (Lopes et al., 1997) and suppress (Borisy and Taylor, 1967 ) microtubule formation, respectively. Pateamine signifi cantly enhanced the tubulin polymerization at 200 μM compared to the 2% ethanol control (Fig. 3A) . In contrast 20 μM pateamine seemed to disrupt polymerization up to the 90 min end point to a level similar to that achieved by the same concentration of colchicine ( Fig. 3B ) with end point values not signifi cantly distinguishable (P > 0.03, using a heteroscedastic Student's t-test based on absorbance values obtained between 88 and 93 min from three independent experiments performed in triplicate).
High concentrations of pateamine disrupt polymerization of rabbit α-actin in vitro
Pyrene-labelled actin was used to assess the in vitro effect of pateamine on microfi lament formation (Kouyama and Mihashi, 1981) . Fig. 4 shows that pateamine caused concentration-dependent suppression of both the initial rate of actin polymerization and the maximum fl uorescence intensity attained indicating that a lower abundance of polymerized actin fi lament is formed, thus higher concentrations of non-polymerized actin remained in solution with higher concentrations of pateamine. Although evident at relatively low concentrations the IC 50 values for both effects were well above 100 μM.
Pateamine does not specifi cally disrupt cell cycle progression
Given the well-established roles of both the actin microfi laments and microtubules in mitosis and the observation that drugs that target these proteins tend to cause a change in the distribution of cells across the cell cycle (Lee and Keng, 2005; Lopes et al., 1997) , the effects of pateamine on cell cycle distribution were studied using fl ow cytometry. At all concentrations tested pateamine caused a statistically signifi cant increase in the amount of small debris in the sub-G 1 region (Fig. 5) (unpaired t-test, P < 0.0003) corresponding to an increase in apoptotic bodies, however, there was no evidence of cell cycle re-distribution as would be expected from compounds acting through actin or microtubule dynamics. This lack of cell-cycle effect was retained across a range of pateamine concentrations and potentially refl ects rapid onset of apoptosis under the infl uence of pateamine. This was confi rmed by identifi cation of statistically signifi cant caspase 3/7 activation and loss of phosphatidylserine asymmetry (data not shown). 
Discussion
Although it has been shown previously that eIF4A is inhibited by pateamine (Bordeleau et al., 2005; Low et al., 2005) , there were indications that pateamine may interact with multiple targets. In the current study we have used affi nity chromatography to confi rm our earlier observations of the interaction between pateamine and eIF4A and have now shown that eIF4A actin and tubulin are the only proteins signifi cantly retained by pateamine from three representative mammalian cell lines. Whilst we did not isolate the DNA polymerases identifi ed by Kuznetsov et al. (2009) , this was expected as our cytosolic preparation would have excluded the nuclear fraction. Table I summarizes the concentrations of pateamine required for functional effects against its full range of targets which has now been shown to include actin and tubulin. The impact on actin fi lament formation and microtubule stabilization occur only at concentrations much higher than those recorded for other targets, whilst the ability to destabilize microtubules occurs at a concentration similar to that required for effects on other targets although only noted at concentrations above those that lead to eIF4A inhibition. Microtubules are a common target for a number of cytotoxic compounds including the destabilizer colchicine (Borisy and Taylor, 1967) as well as the taxanes epothilones and peloruside A that stabilize microtubules (Hood et al., 2002; Jordan and Wilson, 2004; Singh et al., 2008) .
To confi rm that targeting microtubules and actin was not contributing signifi cantly towards the cellular activity of pateamine cell cycle analysis was undertaken. Agents such as paclitaxel and colchicine that interfere with microtubule dynamics generally disrupt mitosis. In mammalian cells mitotic arrest leads to failure to pro- gress through the G 2 /M phase checkpoint of the cell cycle providing a characteristic marker on fl ow cytometric analysis (Honore et al., 2005) . Pateamine treatment did not lead to G 2 /M blockade nor did it result in failure to complete cytokinesis as is generally observed with compounds that inhibit actin function (Usui et al., 2004) , but rather induced apoptosis in the absence of statistically signifi cant changes in the ratios of G 1 , S, and G 2 /M cell populations. These results are consistent with those of Kuznetsov et al. (2009) according to which pateamine induced an S phase block in U-937 cells with no observable change in the G 2 /M population. Interestingly the same study found no S phase block in COLO 205 or MDA-MB-435 cell lines despite the inhibition of DNA synthesis in the latter. On this basis an S phase effect cannot be ruled out for the HeLa cell line used here. However, the lack of an G 2 /M block in HeLa cells suggests that effects on microtubules and actin fi laments are unlikely to contribute signifi cantly to the activity of pateamine. Quiescent cells are more resistant to pateamine (Northcote et al., 1991; Kuznetsov et al., 2009) . Cap-dependent translation initiation is non-essential in quiescent cells (Miskimins et al., 2001) ; since pateamine targets eIF4AI/II the resistance of these cells to pateamine is understandable, however, it would be expected that for these reasons pateamine should induce a G 1 cell cycle block (Huang et al., 2003) . Furthermore knockdown of eIF4AIII in Drosophila cells causes a decrease in the G 2 /M cell population (Boutros et al., 2004) . Neither of these effects were observed by Kuznetsov et al. (2009) or in the current study using HeLa cells. Therefore a complete appreciation of the activity of pateamine must take into account the relative inhibition of eIF4AI/II, eIF4AIII, and DNA polymerase, the combined effect of which is to cause apoptosis at all stages of the cell cycle.
In the present study we have demonstrated an approach to the ascription of accurate biological ontologies to small molecules. The use of chemical proteomic approaches to identify targets in an impartial fashion coupled with in vitro assays against isolated targets and cell-based assays provides an important array of target-related information. Given the different strengths and weaknesses of the various techniques used, a full picture of activity is only revealed when such an array of approaches is used. The set of targets addressed by pateamine cover many of the pathways that would be desirable in a potent biologically active molecule, i.e. the synthesis of proteins and DNA along with perturbation of the cytoskeleton. Pateamine therefore provides an interesting starting point for programmes targeting any of these processes.
Experimental
Mammalian cell line maintenance and MTT assay HL-60, HeLa, and SH-SY5Y cell lines were cultured according to standard tissue culture techniques (Freshney, 2005) . Briefl y all cell lines were grown in RPMI 1640 (GIBCO, Life Technologies New Zealand Limited, Auckland, New Zealand) medium supplemented with 10% foetal calf serum (FCS) and 1% penicillin/streptomycin (PenStrep) in a humidifi ed incubator at 37 ºC and 5% CO 2 . HL-60 cells were passaged by ten-fold dilution in fresh medium when the cell density reached 2 · 10 5 cells/ml. HeLa and SH-SY5Y cells were passaged after removal by trypsin treatment [2.5 mg/ml porcine trypsin in Hank's balanced salt solution (HBSS)] after reaching 70% confl uence and were diluted tenfold on re-seeding. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed as previously reported by Hood et al. (2001) .
Pateamine affi nity chromatography
The pateamine-substituted affi nity resin and a control resin were generated and used as pre viously reported (Bordeleau et al., 2005) . Pateamine and control resin (30 μl each) were equilibrated in 0.5 ml of 0.1% Triton X-100 in 10 mM phosphate-buffered saline (PBS) (SigmaAldrich, St. Louis, MO, USA) for 30 min at 4 °C and washed with another 0.5 ml of the same buffer. The resins were incubated in 1 ml of cell lysate adjusted to a protein concentration of 1 mg/ml for 30 min with agitation for 30 min at 4 °C. Lysates were prepared from either 1 · 10 7 HL-60, SH-SY5Y, or HeLa cells that had been washed three times with 20 ml of ice-cold PBS and disrupted in 5 ml cold PBS with Complete Mini Protease Inhibitor tablets (Roche Dia-gnostics, Mannheim, Germany) with a Dounce homogenizer. Triton X-100 was added to a final content of 0.1%, the homogenate rotated at 4 °C for 30 min and cleared by centrifugation at 100000 x g for 30 min (SS-34 rotor Evolution RC Sorvall; Thermo Fisher Scientifi c, Waltham, MA, USA). Beads were recovered by centrifugation and washed three times with 0.1% Triton X-100 in PBS. Bound proteins were eluted by addition of 30 μl of 2x LDS-PAGE (lithium dodecylsulfate polyacrylamide gel electrophoresis) sample loading buffer with reducing agent (Invitrogen, Carlsbad, CA, USA) and incubation at 70 °C for 10 min. Alternatively a high salt wash was performed with 1 M sodium chloride and 0.1% Triton X-100 in PBS, and the remaining proteins were eluted with LDS-PAGE loading buffer. Eluted proteins were separated using the NuPAGE LDS-PAGE system (Invitrogen) on 4 -12% gradient gels under reducing condition in 3-(N-morpholino)propanesulfonic acid (MOPS) buffer according to the manufacturer's instructions and visualized using standard colloidal Coomassie stain.
Identifi cation of pateamine-binding proteins
Protein bands of interest were excised from the gel, de-stained, and subjected to in-gel trypsin digest following standard procedures (Young et al., 2009) . The resulting peptides were purifi ed using ZipTips-C18 (Millipore, Bedford, MA, USA) according to the manufacturer's instructions. Mass spectra were acquired using an Applied Biosystems DEPro MALDI-TOF mass spectrometer (Framingham, MA, USA) in positive ion refl ector mode with accelerating voltage of 20000 V, grid voltage of 75%, and 180 ns delay time. Peptide masses were calibrated internally using trypsin autolysis peaks. The resulting mass peak list was used to search all eukaryotic species in the NCBI protein database via the ProFound search engine (http://prowl. rockefeller.edu/prowl-cgi/profound.exe) (Zhang and Chait, 2000) allowing for methionine oxidation and acetamide adducts. A positive identification was considered achieved when more than fi ve peptide masses were matched covering more than 25% of the peptide sequence with a mass error tolerance of 25 ppm and an expectation below 0.01.
Tubulin polymerization assay
Bovine microtubules were purifi ed from the brain of an adult cow according to the method of Hamel and Lin (1981) , and tubulin polymerization was followed by a variant of the turbidity assay of Gaskin et al. (1974) using tubulin in polymerization buffer (2 mg/ml, 95 μl), pateamine in 5 μl of 40% ethanol for fi nal concentrations of 20, 100, and 200 μM ethanol (2%) as a carrier control, colchicine (20 μM) and paclitaxel (20 μM) as controls for microtubule destabilization and stabilization, respectively. Absorbance at 350 nm was recorded every 1.5 min for 93 min in a microtitre plate reader (VersaMax; Molecular Devices, Sunnyvale, CA, USA).
Pyrene-actin microfi lament polymerization assay
In vitro actin polymerization was assessed using pyrene-labelled actin (Kouyama and Mihashi, 1981) . The Actin Polymerization Biochem kit (Cytoskeleton Inc., Denver, CO, USA) was used according to the manufacturer's instructions. Pateamine was added in 5 μl DMSO for a fi nal concentration range of 25 -200 μM, 5 μl of DMSO were included as a carrier control. Polymerization was monitored on a fl uorescent microtitre plate reader (SpectraMax Gemini; Molecular Devices), with excitation at 365 nm and monitoring emission at 407 nm, every 5 min for 1 h.
Cell cycle analysis
A 24-well plate was seeded with 2 · 10 5 HeLa cells and left overnight to attach in a humidifi ed incubator at 37 °C with 5% CO 2 . Cells were treated with 10 nM, 25 nM, or 100 nM pateamine in RPMI 1640 medium supplemented with 10% FCS, 1% penicillin/streptomycin, and 0.1% ethanol for 18 h in a humidifi ed incubator at 37 °C and 5% CO 2 , after which they were harvested with trypsin, washed twice with 1 ml of PBS, and their cell cycle distribution analysed by fl ow cytometry (Hood et al., 2001) .
